1. Home
  2. PDC vs CTSO Comparison

PDC vs CTSO Comparison

Compare PDC & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perpetuals.com Ltd American Depositary Shares

PDC

Perpetuals.com Ltd American Depositary Shares

BUY

Current Price

$3.30

Market Cap

24.2M

Sector

Technology

ML Signal

BUY

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$4.50

Market Cap

23.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDC
CTSO
Founded
2018
1997
Country
Japan
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.2M
23.9M
IPO Year
2022
2008

Fundamental Metrics

Financial Performance
Metric
PDC
CTSO
Price
$3.30
$4.50
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $5.38
AVG Volume (30 Days)
33.3K
★ 336.2K
Earning Date
07-01-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 65.79
EPS
★ N/A
N/A
Revenue
N/A
★ $22,503,908.00
Revenue This Year
N/A
$10.34
Revenue Next Year
N/A
$22.41
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 48.53
52 Week Low
$2.42
$0.30
52 Week High
$8.40
$7.44

Technical Indicators

Market Signals
Indicator
PDC
CTSO
Relative Strength Index (RSI) 48.25 58.40
Support Level $2.64 $0.47
Resistance Level $3.64 $7.44
Average True Range (ATR) 0.44 0.58
MACD 0.08 -0.20
Stochastic Oscillator 34.74 12.57

Price Performance

Historical Comparison
PDC
CTSO

About PDC Perpetuals.com Ltd American Depositary Shares

Perpetuals.com Ltd is a financial technology company bridging traditional financial markets with blockchain-based infrastructure. The group operates regulated financial market infrastructure at the intersection of traditional finance and digital assets. Its B2B offerings include capital markets technology delivered as SaaS and institutional-grade custody through Crypto Vault. For consumers, it provides compliant retail trading and prediction market platforms. The group's operations across the USA, Europe, and Asia develop software solutions that enable regulated trading venues to operate with 24/7 self-clearing and blockchain-based settlement technology, empowering institutions to compete in the evolving landscape of digital finance.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: